retatrutide nash nonalcoholic fatty liver disease trial Trial comparing time-restricted eating (TRE) vs. basic Calorie retatrutide nonalcoholic fatty liver disease

Other efficacy assessments include measurement of neck circumference, blood oxygen saturation and patientreported outcomes, as detailed below

review at 4 mg, 9 mg, 12 mg Best For Mirrors current Phase 3 maintenance arms Approach Slow titration Duration Add 2-4 weeks per dose step when GI symptoms persist Review Point Each dose step Best For When nausea, vomiting, or diarrhea is hard to tolerate Trial protocols allowed participants to stay at the current dose for an extra 2-4 weeks when GI side effects were significant

[2] [3] This approach requires careful consideration of your overall treatment goals, other medical conditions, and NICE guidance for your specific situation

Your doctor will start you on a low dose and gradually increase it to minimise discomfort

If you injected Wegovy, you can throw away the entire pen in your FDA-cleared sharps disposal container

The math matters here